Tositumomab

From Anvita Health Wiki

Contents 1 Introduction 2 Indications 3 Mechanism-of-action 4 More General Terms 5 References

Introduction

• Tradename: Bexxar ( FDA approved 2003)

Indications

• refractory non-Hodgkin's lymphoma

Mechanism-of-action

• radiolabeled monoclonal antibody against CD20

More General Terms

• monoclonal antibody
• antineoplastic agent (chemotherapeutic agent)

References

Prescriber's Letter 11(2):suppl 2004

tositumomab (Bexxar)